rs10415568 - UNC13A

Magnitude 2.2 · 1 study on file

Reported associations

  • Genome‐wide association studies identify novel loci in rapidly progressive Alzheimer's disease - Unknown journal (n.d.) · Unknown authors · PubMed 38184787

    ABSTRACT: Abstract INTRODUCTION Recent data suggest that distinct prion‐like amyloid beta and tau strains are associated with rapidly progressive Alzheimer's disease (rpAD). The role of genetic factors in rpAD is largely unknown. METHODS Previously known AD risk loci were examined in rpAD cases. Genome‐wide association studies (GWAS) were performed to identify variants that influence rpAD. RESULTS We identified 115 pathology‐confirmed rpAD cases and 193 clinical rpAD cases, 80% and 69% were of non‐Hispanic European ancestry. Compared to the clinical cohort, pathology‐confirmed rpAD had higher frequencies of apolipoprotein E (APOE) ε4 and rare missense variants in AD risk genes. A novel genome‐wide significant locus (P < 5×10−8) was observed for clinical rpAD on chromosom


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Screening

  • Cognitive function and memory changes Moderate

    Genetic variant associated with increased risk of rapidly progressive Alzheimer's disease, warranting heightened surveillance

    Seek evaluation if memory changes noticed; consider baseline cognitive testing